Cargando…
In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
CHF5633 is a novel synthetic clinical pulmonary surfactant preparation composed by two phospholipid species, dipalmitoyl phosphatidylcholine (DPPC) and palmitoyloleoyl phosphatidylglycerol (POPG), and synthetic analogues of the hydrophobic surfactant proteins SP-B and SP-C. In this study, the interf...
Autores principales: | Echaide, Mercedes, Autilio, Chiara, López-Rodríguez, Elena, Cruz, Antonio, Pérez-Gil, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987218/ https://www.ncbi.nlm.nih.gov/pubmed/31992800 http://dx.doi.org/10.1038/s41598-020-58248-4 |
Ejemplares similares
-
Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome
por: Autilio, Chiara, et al.
Publicado: (2018) -
Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
por: Lugones, Yuliannis, et al.
Publicado: (2018) -
Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways
por: García-Mouton, Cristina, et al.
Publicado: (2021) -
Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse
por: Paget, Tamara L., et al.
Publicado: (2021) -
Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice
por: Madsen, Jens, et al.
Publicado: (2018)